Friday, November 14, 2003

OncoLink at CFS 2003

OncoLink's daily online reports from the Chemotherapy Foundation Symposium in New York City on November 12-14, 2003. For those users interested in obtaining CME for this program, please enter the CME portion of this course.

OncoLink at CFS 2003
New York City

Bevacizumab (Avastin) in Advanced Prostate Cancer
CT-2103 (Xyotax): Phase II Trial of a Polyglutamated Paclitaxel Conjugate in Advanced NSCLC
Erlotinib (Tarceva) and Bevacizumab (Avastin): Combination Therapy for NSCLC
Erythropoietic Agents: Recent Clinical Data
IImpact and Therapeutic Implications of Anemia in Lung Cancer
Molecular Prediction of Response and Survival in NSCLC
Neutropenia Control: Optimising Therapeutic Gains
Novel Approaches in Stage III NSCLC
Optimized Schedule of Weekly Paclitaxel Alone and With Carboplatin: Elderly Advanced NSCLC Patients
Tumor Markers and the Early Detection of Lung Cancer

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More